Global Orphan Drugs Market Research Report
2017
No of Pages – 115
Publishing Date - March 27, 2017
Browse detailed TOC, Tables, Figures, Charts in Global Orphan Drugs Market Research
Report 2017 at - http://www.360marketupdates.com/10553469
In this report, the global Orphan Drugs market is valued at USD XX million in 2016 and is expected
to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption,
revenue (million USD), market share and growth rate of Orphan Drugs in these regions, from 2012 to
2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Orphan Drugs market competition by top manufacturers, with production, price, revenue
(value) and market share for each manufacturer; the top players including
Bayer
Bristol-Myers Squibb
Novartis
Pfizer
Roche
Sanofi
Johnson & Johnson
Eli Lilly & Co.
Celgene
Biogen IDEC
Pharmacyclics
Vertex
Onyx
AstraZeneca
Baxter
On the basis of product, this report displays the production, revenue, price, market share and growth
rate of each type, primarily split into
New Molecular Entities Drugs
Biologics Drugs
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major
applications/end users, consumption (sales), market share and growth rate of Orphan Drugs for each